Gilead target price raised to $181 from $158 by Truist Securities
GILD•Truist Securities raised its target price on Gilead to $181 from $158.
Related News
AbbVie Q3 revenue beats expectations on neuroscience portfolio expansion; raises outlook
ABBV•
Clarivate Plc: Morgan Stanley resumes coverage with underweight rating; target price $1.5
CLVT•
Marvell's optical deal looks dangerously myopic
MRVL•
Organon declares quarterly dividend of $0.02 per share
OGN•
Applied Digital Corporation: B. Riley cuts target price to $51 from $75
APLD•